Results summary | View all lists in L2L MDB | View all genes in R03A.profile.u50 |
Upregulated by DAC treatment in at least one of four pancreatic cancer cell lines, but not in normal (HPDE) cells enrichment: 2.47-fold |
![]() |
![]() | |||||||||||
Probe ID | Name | G | T | D | X | E | P | R | C | S | ![]() |
![]() |
Description |
204597_X_AT | STC1 | C | S | ![]() |
![]() |
stanniocalcin 1 | |||||||
33304_AT | ISG20 | G | R | ![]() |
![]() |
interferon stimulated exonuclease gene 20kDa | |||||||
38037_AT | HBEGF | G | D | X | S | ![]() |
![]() |
heparin-binding EGF-like growth factor | |||||
201926_S_AT | CD55 | X | P | ![]() |
![]() |
CD55 molecule, decay accelerating factor for complement (Cromer blood group) |